Suchergebnisse - "MIZUNUMA, H"

PubPharm (232)

1

A case of ovarian small cell carcinoma of the pulmonary type that was observed as it developed

enthalten in: European journal of gynaecological oncology | 2016

von Kumasaka, R. | Yokoyama, Y. | Fuchinoue, K. | +5

2

Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models

enthalten in: Cancer gene therapy | 2016

von Kobayashi, A. | Yokoyama, Y. | Osawa, Y. | +2

3

Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models

enthalten in: Cancer gene therapy | 2016

von Kobayashi, A. | Yokoyama, Y. | Osawa, Y. | +2

4

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2015

von Nakamura, T. | Ito, M. | Hashimoto, J. | +30

5

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international | 2015

von Nakamura, T. | Ito, M. | Hashimoto, J. | +7

6

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international | 2015

von Nakamura, T. | Ito, M. | Hashimoto, J. | +7

7

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international | 2015

von Nakamura, T. | Ito, M. | Hashimoto, J. | +7

8

Erratum to : efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2015

von Sakai, A. | Ito, M. | Tomomitsu, T. | +20

ErratumFor: Osteoporos Int. 2015 Mar;26(3):1193-202. - PMID 25592133

9

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2015

von Sakai, A. | Ito, M. | Tomomitsu, T. | +8

ErratumIn: Osteoporos Int. 2015 Apr;26(4):1453. - PMID 25656519

10

Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis

enthalten in: Osteoporosis international | 2015

von Sakai, A. | Ito, M. | Tomomitsu, T. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]